These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8236626)

  • 1. Food and drug regulatory issues.
    Stribling J; Picut C
    Vet Clin North Am Small Anim Pract; 1993 Sep; 23(5):991-1005. PubMed ID: 8236626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications for the FDA/Center for Veterinary Medicine (CVM).
    Geyer RE
    J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592
    [No Abstract]   [Full Text] [Related]  

  • 3. Problems associated with veterinary compounding in swine practice.
    McKean JD
    J Am Vet Med Assoc; 1994 Jul; 205(2):279-83. PubMed ID: 7928598
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacist compounding vs veterinarian compounding: similarities and differences.
    Jordan DG
    J Am Vet Med Assoc; 1994 Jul; 205(2):256-60. PubMed ID: 7928593
    [No Abstract]   [Full Text] [Related]  

  • 5. Scientific basis for nonapproved use of drugs in veterinary practice.
    Brumbaugh GW
    J Am Vet Med Assoc; 1993 May; 202(10):1693-6;discussion 1713-7. PubMed ID: 8514586
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of risk assessment and management principles to the extralabel use of drugs in food-producing animals.
    Gehring R; Baynes RE; Riviere JE
    J Vet Pharmacol Ther; 2006 Feb; 29(1):5-14. PubMed ID: 16420296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compounding for animal patients: contemporary issues.
    Lust E
    J Am Pharm Assoc (2003); 2004; 44(3):375-84; quiz 384-6. PubMed ID: 15191248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current FDA policy on use of human-labeled drugs in animals.
    Teske RH
    J Am Vet Med Assoc; 1993 May; 202(10):1632-3;discussion 1634. PubMed ID: 8514570
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of animal toxicoses: a regulatory perspective.
    Bright SJ; Murphy MJ; Steinschneider JC; Lovell RA; Post LO
    Vet Clin North Am Food Anim Pract; 2011 Jul; 27(2):481-512, x. PubMed ID: 21575782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compounding forum: FDA-CVM hears veterinarians' views.
    J Am Vet Med Assoc; 1993 Nov; 203(10):1367-72. PubMed ID: 8276690
    [No Abstract]   [Full Text] [Related]  

  • 11. Extralabel drug use and compounding in veterinary medicine.
    Geyer RE
    Food Drug Law J; 1997; 52(3):291-5. PubMed ID: 10343027
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormonal and antimicrobial therapy in theriogenology practice: currently approved drugs in the USA and possible future directions.
    Modric T; Momcilovic D; Gwin WE; Peter AT
    Theriogenology; 2011 Aug; 76(3):393-408. PubMed ID: 21601267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of FDA-approved drugs in veterinary medicine: prerogatives and responsibilities.
    Mann CJ
    J Am Vet Med Assoc; 1993 May; 202(10):1674-7;discussion 1684-92. PubMed ID: 8514581
    [No Abstract]   [Full Text] [Related]  

  • 14. Label and extra label drug use in small ruminants.
    Fajt VR
    Vet Clin North Am Food Anim Pract; 2001 Jul; 17(2):403-20. PubMed ID: 11515408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helpful tips for extralabel drug use: record keeping, record access, and product labels. The FDA-Center for Veterinary Medicine and the American Veterinary Medicine Association.
    J Am Vet Med Assoc; 1998 Mar; 212(5):666-7. PubMed ID: 9556375
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA/CVM's Compliance Policy Guide on compounding of drugs.
    J Am Vet Med Assoc; 1996 Dec; 209(12):2025-9. PubMed ID: 8960175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance policy guideline enforcement issues.
    Mitchell B
    J Am Vet Med Assoc; 1994 Jul; 205(2):201-2. PubMed ID: 7928574
    [No Abstract]   [Full Text] [Related]  

  • 18. Responsibilities under an amended Food, Drug & Cosmetic Act: equine practitioners.
    Macomber LE
    J Am Vet Med Assoc; 1993 May; 202(10):1735;discussion 1740-1. PubMed ID: 8514598
    [No Abstract]   [Full Text] [Related]  

  • 19. Compounding and Extralabel Use of Drugs in Exotic Animal Medicine.
    Powers LV; Davidson G
    Vet Clin North Am Exot Anim Pract; 2018 May; 21(2):195-214. PubMed ID: 29655467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA calls for voluntary label changes,increased veterinarian oversight.
    Cima G
    J Am Vet Med Assoc; 2012 Jun; 240(11):1266-8. PubMed ID: 22774262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.